Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer Read more
Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment Read more
FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy Read more
Aldevron Selects AES, Begins Construction of Cleanrooms in $30 Million GMP Plasmid Facility Read more